Compound Detail
CHEMBL3707313
TRIFAROTENE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL3707313 |
| Name | TRIFAROTENE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | MFBCDACCJCDGBA-UHFFFAOYSA-N |
3
Targets
6
Activities
2
Assay Types
1
PK Parameters
7
Publications
5
Known Names
3
Indications
1
Mechanisms
Molecular Properties
459.6
MW (Da)
5.99
ALogP
4
HBA
2
HBD
70.0
PSA (Ų)
0.45
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2019 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Retinoic acid receptor gamma agonist | AGONIST | Retinoic acid receptor gamma | ✓ | ✓ |
Indications
Acne Vulgaris Ichthyosis, Lamellar Lymphoma
ATC Classification
D10AD06
trifarotene
Level 1: DERMATOLOGICALS
Level 2: ANTI-ACNE PREPARATIONS
Activity Summary
EC50 3 meas. best 8.11
Kd 3 meas. best 8.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Retinoic acid receptor gamma CHEMBL2003 | Kd | 8.7 | 8.7 | 2.0 | 1 |
| Retinoic acid receptor gamma CHEMBL2003 | EC50 | 8.11 | 8.11 | 7.7 | 1 |
| Retinoic acid receptor beta CHEMBL2008 | Kd | 7.82 | 7.82 | 15.0 | 1 |
| Retinoic acid receptor beta CHEMBL2008 | EC50 | 6.9 | 6.9 | 125.0 | 1 |
| Retinoic acid receptor alpha CHEMBL2055 | EC50 | 6.3 | 6.3 | 500.0 | 1 |
| Retinoic acid receptor alpha CHEMBL2055 | Kd | 6.3 | 6.3 | 500.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Fu | 0.0001 | - | Not specified |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Retinoic acid receptor gamma | Kd | = | 2.0 | nM | 8.7 | Activation of RARgamma (unknown origin) expressed in human HeLa cells co-express... | - |
| Retinoic acid receptor gamma | EC50 | = | 7.7 | nM | 8.11 | Agonist activity at GAL4 DNA-binding domain-tagged RARgamma (unknown origin) lig... | 29706423 |
| Retinoic acid receptor beta | Kd | = | 15.0 | nM | 7.82 | Activation of RARbeta (unknown origin) expressed in human HeLa cells co-expressi... | - |
| Retinoic acid receptor beta | EC50 | = | 125.0 | nM | 6.9 | Agonist activity at GAL4 DNA-binding domain-tagged RARbeta (unknown origin) liga... | 29706423 |
| Retinoic acid receptor alpha | EC50 | = | 500.0 | nM | 6.3 | Agonist activity at GAL4 DNA-binding domain-tagged RARalpha (unknown origin) lig... | 29706423 |
| Retinoic acid receptor alpha | Kd | = | 500.0 | nM | 6.3 | Activation of RARalpha (unknown origin) expressed in human HeLa cells co-express... | - |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29706423 | 10.1016/j.bmcl.2018.04.036 | Unchecked | 2 |
| 29706423 | 10.1016/j.bmcl.2018.04.036 | Retinoic acid receptor gamma | 1 |
| 29706423 | 10.1016/j.bmcl.2018.04.036 | Retinoic acid receptor alpha | 1 |
| 29706423 | 10.1016/j.bmcl.2018.04.036 | Retinoic acid receptor beta | 1 |
| 29706423 | 10.1016/j.bmcl.2018.04.036 | Hepatocyte | 1 |
| 29706423 | 10.1016/j.bmcl.2018.04.036 | No relevant target | 1 |
| 29706423 | 10.1016/j.bmcl.2018.04.036 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine